Colchicine Pharmacology đź’ŠNursing Mode

Share

Summary

An overview of Colchicine as a treatment for acute gout flares, covering its mechanism of action, dosing, adverse effects, and essential nursing monitoring considerations.

Highlights

Introduction to Colchicine and Mechanism00:00:00

Colchicine is an anti-gout medication used for acute flares. Unlike allopurinol or probenecid, it does not lower uric acid levels or address the underlying cause. Instead, it works by blocking neutrophil migration to the site of uric acid crystal accumulation, thereby reducing inflammation and pain.

Dosing and Clinical Use00:02:03

Colchicine is specifically intended for acute gout flares. The typical dosage regimen is 1.2 mg initially, followed by 0.6 mg one hour later, for a total of 1.8 mg on the first day. Because of the high risk of GI toxicity, strict adherence to dosing is required.

Maintenance vs. Acute Treatment00:03:02

Maintenance therapy for chronic gout involves allopurinol to decrease uric acid production and probenecid to increase its excretion. Colchicine is reserved for symptom management during flare-ups rather than long-term uric acid control.

Adverse Effects and Monitoring00:03:54

Common adverse effects include severe gastrointestinal symptoms like diarrhea, nausea, and vomiting, which can be early indicators of toxicity. Other risks include bone marrow suppression (requiring CBC monitoring) and neuromuscular toxicity like rhabdomyolysis. Monitoring renal and hepatic function is critical as impaired clearance increases toxicity risk.

Safety Precautions and Interactions00:05:33

Healthcare providers should monitor for muscle weakness, check lab values, and ensure patients avoid grapefruit products and CYP3A4 or P-glycoprotein inhibitors, which can increase drug levels and toxicity risk.

Recently Summarized Articles

Loading...
Summarize another YouTube video →